B. Riley reaffirmed their buy rating on shares of Gritstone bio (NASDAQ:GRTS – Free Report) in a research note released on Friday, Benzinga reports. B. Riley currently has a $3.00 price target on the stock, down from their previous price target of $6.00. A number of other brokerages also recently commented on GRTS. JMP Securities […]

Related Keywords

, Forum Financial Management , Company Profile , Klingman Associates , Peaks Wealth Advisors , Lazard Asset Management , Tidal Investments , Nasdaq , Free Report , Get Free Report , Investors Weigh In On Gritstone , Financial Management , Asset Management , Twin Peaks Wealth Advisors ,